Your choices go into the PDF (cover and captions); this bar does not.
Rebalix
Comparison report · official data side by side

IE00B3SC9K16 vs IE00BD4TXS21


IE00B3SC9K16UBS MSCI USA SF UCITS ETF USD acc
IE00B3SC9K16 · Equity
IE00BD4TXS21UBS Core MSCI USA UCITS ETF USD acc
IE00BD4TXS21 · Equity · United States
Open the interactive comparison on rebalix.com →

Comparison window: 16 Sept 20168 Sept 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared

Report produced on 10 September 2026 · data as of the dates shown per section
Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat
Public methodology: rebalix.com/en/methodology

Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.

RebalixIE00B3SC9K16 vs IE00BD4TXS21 · report of 10 September 2026

The funds at a glance

From official issuer documents and the ESMA register
IE00B3SC9K16IE00B3SC9K16UBS MSCI USA SF UCITS ETF USD accEquity
Declared index
MSCI USA Total Return Net
TER
0.15%
Transaction (KID)
0.00%
Fund size
Launch
15 Dec 2010
Currency
USD
Replication
Synthetic (swap)
Hedging
No
Holdings
Effective 🇮🇹 rate
IE00BD4TXS21IE00BD4TXS21UBS Core MSCI USA UCITS ETF USD accEquity · United States
Declared index
MSCI USA Total Return Net
TER
0.03%
Transaction (KID)
0.00%
Fund size
2.7 mld EUR
Launch
16 Sept 2016
Currency
USD
Replication
Physical (full replication)
Hedging
No
Holdings
520
Effective 🇮🇹 rate
26.00%

Tracking difference — year by year

Fund minus index, from issuer-declared series (complete calendar years). Each measures adherence to its OWN index.
IE00B3SC9K163y avg: +0.16%/anno
2025
+0.09%
2024
+0.14%
2023
+0.26%
2022
+0.19%
2021
+0.18%
2020
+0.42%
IE00BD4TXS213y avg: +0.18%/anno
2025
+0.18%
2024
+0.17%
2023
+0.18%
2022
+0.09%
2021
+0.09%
2020
+0.16%
Rebalix · IE00B3SC9K16 vs IE00BD4TXS21section 1 of 3
RebalixIE00B3SC9K16 vs IE00BD4TXS21 · report of 10 September 2026
IE00B3SC9K16UBS MSCI USA SF UCITS ETF USD acc · IE00B3SC9K16 · Equity
IE00BD4TXS21UBS Core MSCI USA UCITS ETF USD acc · IE00BD4TXS21 · Equity · United States

Performance over the period, in euro

From 16 Sept 2016 to 8 Sept 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
10040599395394
In today’s purchasing power (net of Italy inflation)
10040599312311
IE00B3SC9K16IE00BD4TXS21
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.

How far they fell — drawdown from peak (nominal)

In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
0%-10%-20%-30%-40%-50%IE00B3SC9K16IE00BD4TXS212017201820192020202120222023202420252026trough IE00B3SC9K16: −34.0% · 23 Mar 2020trough IE00BD4TXS21: −34.0% · 23 Mar 2020
Filled area: IE00B3SC9K16; thin lines: the other funds.
The worst episode, fund by fund
FundMax drawdownTroughRecovery timeUnderwater
IE00B3SC9K16−34.0%23 Mar 2020238 days271 days · back to break-even on 16 Nov 2020
IE00BD4TXS21−34.0%23 Mar 2020246 days279 days · back to break-even on 24 Nov 2020
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.

Drawdown net of Italy inflation

Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
0%-10%-20%-30%-40%-50%IE00B3SC9K16IE00BD4TXS212017201820192020202120222023202420252026trough IE00B3SC9K16: −35.4% · 23 Mar 2020trough IE00BD4TXS21: −35.4% · 23 Mar 2020
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
Rebalix · IE00B3SC9K16 vs IE00BD4TXS21section 2 of 3
RebalixIE00B3SC9K16 vs IE00BD4TXS21 · report of 10 September 2026

Full comparison table

"—" = not published by the source, never estimated
IE00B3SC9K16UBS MSCI USA SF UCITS ETF USD acc · IE00B3SC9K16 · Equity
IE00BD4TXS21UBS Core MSCI USA UCITS ETF USD acc · IE00BD4TXS21 · Equity · United States
MetricIE00B3SC9K16IE00BD4TXS21Note
Identity
CategoryEquityEquity · United StatesRebalix engine classification
ReplicationSynthetic (swap)Physical (full replication)as declared by the issuer
Currency hedgingNoNosource: class name, factsheet
Income policyaccumulatingaccumulating
Costs
TER0.15%0.03%from the KID
Transaction costs (KID)0.00%0.00%internal
All-in cost0.15%0.03%TER + transaction
Tracking difference (3a)+0.16%+0.18%vs its OWN index
Performance in euro (ECB rates)
1 year+19.9%+20.1%
3 years+63.8%+64.1%
5 years+79.7%+79.8%
10 years+287.6%+294.4%— = series younger than the window
Risk · last 3 years
Volatility (ann.)+15.23%+15.16%
Max drawdown−19.16%−19.15%
Sharpe1.141.14risk-free = ECB MRO avg
Sortino1.671.67like Sharpe, downside only
Italian taxation
Effective capital-gains rate26.00%white list, current half-year
Documents & exchanges
Listing venues9ESMA register
Borsa Italiana tickerUSAUSW
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~95 euro IE00B3SC9K16 · ~19 euro IE00BD4TXS21. Broker costs not included.

Disclaimer

This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.

Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.

Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.

Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.

Rebalix · IE00B3SC9K16 vs IE00BD4TXS21section 3 of 3